[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Pfizer Inc (PFE)

Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 149,211,440
  • Shares Outstanding, K 5,699,444
  • Annual Sales, $ 62,579 M
  • Annual Income, $ 7,771 M
  • EBIT $ 19,384 M
  • EBITDA $ 25,976 M
  • 60-Month Beta 0.35
  • Price/Sales 2.38
  • Price/Cash Flow 5.95
  • Price/Book 1.65

Options Overview Details

View History
  • Implied Volatility 23.01% (+0.33%)
  • Historical Volatility 16.48%
  • IV Percentile 26%
  • IV Rank 29.91%
  • IV High 34.15% on 10/10/25
  • IV Low 18.25% on 08/18/25
  • Expected Move (DTE 6) 0.51 (1.95%)
  • Put/Call Vol Ratio 0.44
  • Today's Volume 106,713
  • Volume Avg (30-Day) 122,048
  • Put/Call OI Ratio 0.83
  • Today's Open Interest 2,615,886
  • Open Int (30-Day) 2,578,844
  • Expected Range 25.67 to 26.69

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 28 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $0.67
  • Number of Estimates 7
  • High Estimate $0.72
  • Low Estimate $0.64
  • Prior Year $0.78
  • Growth Rate Est. (year over year) -14.10%

Price Performance

See More
Period Period Low Period High Performance
1-Month
25.19 +3.93%
on 05/18/26
26.91 -2.71%
on 04/30/26
-0.08 (-0.30%)
since 04/29/26
3-Month
25.19 +3.93%
on 05/18/26
28.75 -8.92%
on 04/02/26
-1.47 (-5.32%)
since 02/27/26
52-Week
23.06 +13.53%
on 06/03/25
28.75 -8.92%
on 04/02/26
+3.00 (+12.94%)
since 05/28/25

Most Recent Stories

More News
TALZENNA Plus XTANDI Improves Radiographic Progression-Free Survival by More Than 50% in Metastatic Prostate Cancer

First PARP inhibitor + ARPI combination to show consistent rPFS improvement in HRR gene‑altered metastatic hormone‑sensitive prostate cancer, including both BRCA and non‑BRCA alterations ...

PFE : 26.18 (+0.15%)
Seven-Year Analysis from Pfizer’s LORBRENA CROWN Trial Shows Longest Progression-Free Survival Reported to Date in Advanced Non-Small Cell Lung Cancer

Patients had a 55% likelihood of remaining alive without disease progression at seven years, and median progression-free survival was not reached with LORBRENA ...

PFE : 26.18 (+0.15%)
Pfizer and Innovent Biologics Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines

Pfizer Inc. (NYSE: PFE) and Innovent Biologics, Inc. (01801.HK), today announced the companies have entered into a strategic global licensing and collaboration agreement for the research and development...

PFE : 26.18 (+0.15%)
1 Stock Under $50 with Solid Fundamentals and 2 We Ignore

1 Stock Under $50 with Solid Fundamentals and 2 We Ignore

ZG : 35.36 (-1.23%)
BSM : 13.56 (+1.88%)
PFE : 26.18 (+0.15%)
Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference

Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a discussion with Albert Bourla, Chairman and Chief Executive Officer, at the Jefferies Global Healthcare...

PFE : 26.18 (+0.15%)
3 Dividend Stocks Yielding Above 5% to Scoop Up Now

These three dividend stocks combine strong yields with resilient businesses.

MO : 69.58 (-3.32%)
VZ : 47.81 (-0.42%)
PFE : 26.18 (+0.15%)
Bear Call Spread Opportunities for May 26

With the market coming into a seasonally weak time of year, Bear Call Spreads could be an interesting trade to consider.

MSFT : 450.24 (+5.45%)
NFLX : 86.02 (-0.39%)
BAC : 51.60 (+1.63%)
JPM : 299.31 (+0.87%)
PG : 143.56 (-1.61%)
UBER : 70.40 (-0.73%)
PFE : 26.18 (+0.15%)
Spotting Winners: Pfizer (NYSE:PFE) And Branded Pharmaceuticals Stocks In Q1

Spotting Winners: Pfizer (NYSE:PFE) And Branded Pharmaceuticals Stocks In Q1

PFE : 26.18 (+0.15%)
Sickly Healthcare Stocks Are Perking Up. For Contrarian Investors, Buying Now Could Be Just the Remedy to Protect Your Portfolio.

Go beyond the broad index and find which segment of healthcare best suits your portfolio needs now.

XLV : 149.47 (-0.93%)
$SPX : 7,580.06 (+0.22%)
MRK : 118.72 (-0.98%)
LLY : 110.50 (-90.19%)
PPH : 104.74 (-0.92%)
IHI : 48.96 (-0.79%)
UNH : 380.31 (-0.58%)
ELV : 393.19 (+0.11%)
PFE : 26.18 (+0.15%)
NIH Infectious Disease Chief Steps Down Amid Ebola and Hantavirus Response Concerns

The acting director of the National Institute of Allergy and Infectious Diseases resigned ahead of a Senate hearing Thursday, adding to leadership turnover across U.S. health agencies during ongoing Ebola...

GILD : 134.43 (-1.31%)
MRNA : 47.19 (-0.80%)
PFE : 26.18 (+0.15%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Pfizer Inc. is a research-based, global biopharmaceutical company. The company boasts a sustainable pipeline with multiple late-stage programs that can drive growth. Pfizer markets a wide range of drugs and vaccines. Its business comprises six business units - Oncology, Inflammation & Immunology, Rare...

See More

Key Turning Points

3rd Resistance Point 26.61
2nd Resistance Point 26.43
1st Resistance Point 26.30
Last Price 26.18
1st Support Level 25.99
2nd Support Level 25.81
3rd Support Level 25.68

See More

52-Week High 28.75
Fibonacci 61.8% 26.57
Last Price 26.18
Fibonacci 50% 25.90
Fibonacci 38.2% 25.23
52-Week Low 23.06

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.